|
1
|
Hayreh SS: Classification of central
retinal vein occlusion. Ophthalmology. 90:458–474. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hayreh SS, Klugman MR, Beri M, Kimura AE
and Podhajsky P: Differentiation of ischemic from non-ischemic
central retinal vein occlusion during the early acute phase.
Graefes Arch Clin Exp Ophthalmol. 228:201–217. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hayreh SS, Rojas P, Podhajsky P, Montague
P and Woolson RF: Ocular neovascularization with retinal vascular
occlusion-III. Incidence of ocular neovascularization with retinal
vein occlusion. Ophthalmology. 90:488–506. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McIntosh RL, Rogers SL, Lim L, Cheung N,
Wang JJ, Mitchell P, Kowalski JW, Nguyen HP and Wong TY: Natural
history of central retinal vein occlusion: An evidence-based
systematic review. Ophthalmology. 117:1113–1123, e1115. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bradshaw SE, Gala S, Nanavaty M, Shah A,
Mwamburi M and Kefalas P: Systematic literature review of
treatments for management of complications of ischemic central
retinal vein occlusion. BMC Ophthalmol. 16:1042016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
No authors listed: Argon laser scatter
photocoagulation for prevention of neovascularization and vitreous
hemorrhage in branch vein occlusion. A randomized clinical trial.
Branch vein occlusion study group. Arch Ophthalmol. 104:34–41.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Newcomb EW, Madonia WJ, Pisharody S, Lang
FF, Koslow M and Miller DC: A correlative study of p53 protein
alteration and p53 gene mutation in glioblastoma multiforme. Brain
Pathol. 3:229–235. 1983. View Article : Google Scholar
|
|
8
|
Magargal LE, Brown GC, Augsburger JJ and
Donoso LA: Efficacy of panretinal photocoagulation in preventing
neovascular glaucoma following ischemic central retinal vein
obstruction. Ophthalmology. 89:780–784. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
No authors listed: Baseline and early
natural history report. The central vein occlusion study. Arch
Ophthalmol. 111:1087–1095. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Evans K, Wishart PK and McGalliard JN:
Neovascular complications after central retinal vein occlusion. Eye
(Lond). 7:520–524. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
No authors listed: A randomized clinical
trial of early panretinal photocoagulation for ischemic central
vein occlusion. The central vein occlusion study group n report.
Ophthalmology. 102:1434–1444. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kjeka O, Jansson RW, Bredrup C and Krohn
J: Early panretinal photocoagulation for ERG-verified ischaemic
central retinal vein occlusion. Acta Ophthalmol. 91:37–41. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arvas S, Ocakoglu O and Ozkan S: The
capillary blood flow in ischaemic type central retinal vein
occlusion: The effect of laser photocoagulation. Acta Ophthalmol
Scand. 80:490–494. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bitirgen G, Belviranli S, Malik RA,
Kerimoglu H and Ozkagnici A: Effects of panretinal laser
photocoagulation on the corneal nerve plexus and retinal nerve
fiber layer in retinal vein occlusion. Eur J Ophthalmol.
27:591–595. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayreh SS, Klugman MR, Podhajsky P,
Servais GE and Perkins ES: Argon laser panretinal photocoagulation
in ischemic central retinal vein occlusion. A 10-year prospective
study. Graefes Arch Clin Exp Ophthalmol. 228:281–296. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laatikainen L, Kohner EM, Khoury D and
Blach RK: Panretinal photocoagulation in central retinal vein
occlusion: A randomised controlled clinical study. Br J Ophthalmol.
61:741–753. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pikkel YY, Sharabi-Nov A, Beiran I and
Pikkel J: Comparison of anti-vascular endothelial growth factors,
laser treatments and a combination of the both for treatment of
central retinal vein occlusion. Int J Ophthalmol. 9:431–433.
2016.PubMed/NCBI
|
|
18
|
Fan F and Pan SX: The clinical efficacy of
panretinal photocoagulation in the treatmnent for ischemic central
retinal vein occlusion. J Prac Prev Blind. 4:156–158. 2011.(In
Chinese).
|
|
19
|
Qu Q, Hong T and Zhou L: Argon-ion laser
treatment of ischemic central retinal vein occlusion: Analysis of
63 cases. World Health Digest. 8:113. 2014.(In Chinese).
|
|
20
|
Cao Y: Therapeutic effect of holmium laser
on 35 cases of central retinal vein occlusion. Shandong Med.
26(47)2006.(In Chinese).
|
|
21
|
Cai J, Cheng J, Li Y and Wei R: Laser
photocoagulation for prevention of neovascular glaucoma due to
central retinal vein occlusion. Chin J Prac Ophthalmol. 1:24–26.
2009.(In Chinese).
|
|
22
|
Muqit MM, Sanghvi C, McLauchlan R, Delgado
C, Young LB, Charles SJ, Marcellino GR and Stanga PE: Study of
clinical applications and safety for Pascal® laser
photocoagulation in retinal vascular disorders. Acta Ophthalmol.
90:155–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mellerio J: The thermal nature of retinal
laser photocoagulation. Exp Eye Res. 5:2421996. View Article : Google Scholar
|
|
24
|
Fong DS, Girach A and Boney A: Visual side
effects of successful scatter laser photocoagulation surgery for
proliferative diabetic retinopathy: A literature review. Retina.
27:816–824. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Central vein occlusion study of
photocoagulation therapy. Baseline findings. Central vein occlusion
study group. Online J Curr Clin Trials. 95:1993.
|
|
26
|
Wald KJ: The CVOS Group M and N reports.
Ophthalmology. 103:352–354. 1996. View Article : Google Scholar : PubMed/NCBI
|
